355 related articles for article (PubMed ID: 34337079)
1. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease.
Yao S; Zhao Z; Wang W; Liu X
J Immunol Res; 2021; 2021():8030297. PubMed ID: 34337079
[TBL] [Abstract][Full Text] [Related]
2. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
3. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease: new therapies from antisense oligonucleotides.
Marafini I; Monteleone G
Ann Med; 2018 Aug; 50(5):361-370. PubMed ID: 29911450
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota.
Ni Y; Zhang Y; Zheng L; Rong N; Yang Y; Gong P; Yang Y; Siwu X; Zhang C; Zhu L; Fu Z
Life Sci; 2023 Jul; 324():121699. PubMed ID: 37061125
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
7. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
Nanini HF; Bernardazzi C; Castro F; de Souza HSP
World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
[TBL] [Abstract][Full Text] [Related]
8. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
Jakubczyk D; Leszczyńska K; Górska S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
[TBL] [Abstract][Full Text] [Related]
9. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease.
Ryan FJ; Ahern AM; Fitzgerald RS; Laserna-Mendieta EJ; Power EM; Clooney AG; O'Donoghue KW; McMurdie PJ; Iwai S; Crits-Christoph A; Sheehan D; Moran C; Flemer B; Zomer AL; Fanning A; O'Callaghan J; Walton J; Temko A; Stack W; Jackson L; Joyce SA; Melgar S; DeSantis TZ; Bell JT; Shanahan F; Claesson MJ
Nat Commun; 2020 Mar; 11(1):1512. PubMed ID: 32251296
[TBL] [Abstract][Full Text] [Related]
10. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders.
Loktionov A
World J Gastroenterol; 2019 Jul; 25(27):3503-3526. PubMed ID: 31367153
[TBL] [Abstract][Full Text] [Related]
11. Reduced CD27
Pararasa C; Zhang N; Tull TJ; Chong MHA; Siu JHY; Guesdon W; Chavele KM; Sanderson JD; Langmead L; Kok K; Spencer J; Vossenkamper A
Front Immunol; 2019; 10():361. PubMed ID: 30891036
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and mucosal defense in IBD: an update.
Stange EF; Schroeder BO
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
[No Abstract] [Full Text] [Related]
13. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
14. The microbiome and inflammatory bowel disease.
Glassner KL; Abraham BP; Quigley EMM
J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
[TBL] [Abstract][Full Text] [Related]
15. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
[TBL] [Abstract][Full Text] [Related]
16. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M; Poola S; Ali S; Samiullah S; Tahan V
Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
[TBL] [Abstract][Full Text] [Related]
18. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
19. Bifidobacterium longum and VSL#3
Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]